Literature DB >> 26394672

Association of Single-Nucleotide Polymorphisms in IL28B, but Not TNF-α, With Severity of Disease Caused by Andes Virus.

Jenniffer Angulo1, Karla Pino1, Natalia Echeverría-Chagas2, Claudia Marco3, Constanza Martínez-Valdebenito3, Héctor Galeno4, Eliecer Villagra4, Lilian Vera4, Natalia Lagos4, Natalia Becerra4, Judith Mora4, Andrea Bermúdez5, Marcela Cárcamo5, Janepsy Díaz5, Juan Francisco Miquel6, Marcela Ferrés3, Marcelo López-Lastra1.   

Abstract

BACKGROUND: Andes virus (ANDV) is the sole etiologic agent of hantavirus cardiopulmonary syndrome (HCPS) in Chile, with a fatality rate of about 35%. Individual host factors affecting ANDV infection outcome are poorly understood. In this case-control genetic association analysis, we explored the link between single-nucleotide polymorphisms (SNPs) rs12979860, rs8099917 and rs1800629 and the clinical outcome of ANDV-induced disease. The SNPs rs12979860 and rs8099917 are known to play a role in the differential expression of the interleukin 28B gene (IL28B), whereas SNP rs1800629 is implicated in the expression of tumor necrosis factor α gene (TNF-α).
METHODS: A total of 238 samples from confirmed ANDV-infected patients collected between 2006 and 2014, and categorized according to the severity of the disease, were genotyped for SNPs rs12979860, rs8099917, and rs1800629.
RESULTS: Analysis of IL28B SNPs rs12979860 and rs8099917 revealed a link between homozygosity of the minor alleles (TT and GG, respectively), displaying a mild disease progression, whereas heterozygosity or homozygosity for the major alleles (CT/CC and TG/TT, respectively) in both IL28B SNPs is associated with severe disease. No association with the clinical outcome of HCPS was observed for TNF-α SNP rs1800629 (TNF -308G>A).
CONCLUSIONS: The IL28B SNPs rs12979860 and rs8099917, but not TNF-α SNP rs1800629, are associated with the clinical outcome of ANDV-induced disease, suggesting a possible link between IL28B expression and ANDV pathogenesis.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  ANDV; HCPS; IL28B; SNP; TNF-alpha

Mesh:

Substances:

Year:  2015        PMID: 26394672      PMCID: PMC4657541          DOI: 10.1093/cid/civ830

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  46 in total

Review 1.  IL28B genomic-based treatment paradigms for patients with chronic hepatitis C infection: the future of personalized HCV therapies.

Authors:  Paul J Clark; Alex J Thompson; John G McHutchison
Journal:  Am J Gastroenterol       Date:  2010-10-05       Impact factor: 10.864

Review 2.  Treatment of hantavirus pulmonary syndrome.

Authors:  Colleen B Jonsson; Jay Hooper; Gregory Mertz
Journal:  Antiviral Res       Date:  2007-11-21       Impact factor: 5.970

3.  OpenEpi: a web-based epidemiologic and statistical calculator for public health.

Authors:  Kevin M Sullivan; Andrew Dean; Minn Minn Soe
Journal:  Public Health Rep       Date:  2009 May-Jun       Impact factor: 2.792

4.  IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C.

Authors:  Thomas J Urban; Alexander J Thompson; Shelton S Bradrick; Jacques Fellay; Detlef Schuppan; Kenneth D Cronin; Linda Hong; Alexander McKenzie; Keyur Patel; Kevin V Shianna; John G McHutchison; David B Goldstein; Nezam Afdhal
Journal:  Hepatology       Date:  2010-10-07       Impact factor: 17.425

5.  T cells are not required for pathogenesis in the Syrian hamster model of hantavirus pulmonary syndrome.

Authors:  Christopher D Hammerbeck; Jay W Hooper
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

6.  Highly differentiated, resting gn-specific memory CD8+ T cells persist years after infection by andes hantavirus.

Authors:  Tobias Manigold; Andrés Mori; Rebecca Graumann; Elena Llop; Valeska Simon; Marcela Ferrés; Francisca Valdivieso; Constanza Castillo; Brian Hjelle; Pablo Vial
Journal:  PLoS Pathog       Date:  2010-02-19       Impact factor: 6.823

7.  Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.

Authors:  Yasuhito Tanaka; Nao Nishida; Masaya Sugiyama; Masayuki Kurosaki; Kentaro Matsuura; Naoya Sakamoto; Mina Nakagawa; Masaaki Korenaga; Keisuke Hino; Shuhei Hige; Yoshito Ito; Eiji Mita; Eiji Tanaka; Satoshi Mochida; Yoshikazu Murawaki; Masao Honda; Akito Sakai; Yoichi Hiasa; Shuhei Nishiguchi; Asako Koike; Isao Sakaida; Masatoshi Imamura; Kiyoaki Ito; Koji Yano; Naohiko Masaki; Fuminaka Sugauchi; Namiki Izumi; Katsushi Tokunaga; Masashi Mizokami
Journal:  Nat Genet       Date:  2009-09-13       Impact factor: 38.330

8.  IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.

Authors:  Vijayaprakash Suppiah; Max Moldovan; Golo Ahlenstiel; Thomas Berg; Martin Weltman; Maria Lorena Abate; Margaret Bassendine; Ulrich Spengler; Gregory J Dore; Elizabeth Powell; Stephen Riordan; David Sheridan; Antonina Smedile; Vincenzo Fragomeli; Tobias Müller; Melanie Bahlo; Graeme J Stewart; David R Booth; Jacob George
Journal:  Nat Genet       Date:  2009-09-13       Impact factor: 38.330

9.  Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies.

Authors:  Santiago Rodriguez; Tom R Gaunt; Ian N M Day
Journal:  Am J Epidemiol       Date:  2009-01-06       Impact factor: 4.897

10.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.

Authors:  David L Thomas; Chloe L Thio; Maureen P Martin; Ying Qi; Dongliang Ge; Colm O'Huigin; Judith Kidd; Kenneth Kidd; Salim I Khakoo; Graeme Alexander; James J Goedert; Gregory D Kirk; Sharyne M Donfield; Hugo R Rosen; Leslie H Tobler; Michael P Busch; John G McHutchison; David B Goldstein; Mary Carrington
Journal:  Nature       Date:  2009-10-08       Impact factor: 49.962

View more
  5 in total

1.  Clinical characterization of two severe cases of hemorrhagic fever with renal syndrome (HFRS) caused by hantaviruses Puumala and Dobrava-Belgrade genotype Sochi.

Authors:  Ellen Krautkrämer; Christian Nusshag; Alexandra Baumann; Julia Schäfer; Jörg Hofmann; Paul Schnitzler; Boris Klempa; Peter T Witkowski; Detlev H Krüger; Martin Zeier
Journal:  BMC Infect Dis       Date:  2016-11-14       Impact factor: 3.090

2.  Serum levels of interleukin-6 are linked to the severity of the disease caused by Andes Virus.

Authors:  Jenniffer Angulo; Constanza Martínez-Valdebenito; Claudia Marco; Héctor Galeno; Eliecer Villagra; Lilian Vera; Natalia Lagos; Natalia Becerra; Judith Mora; Andrea Bermúdez; Janepsy Díaz; Marcela Ferrés; Marcelo López-Lastra
Journal:  PLoS Negl Trop Dis       Date:  2017-07-14

Review 3.  Interferon Lambda: Modulating Immunity in Infectious Diseases.

Authors:  Mohammedyaseen Syedbasha; Adrian Egli
Journal:  Front Immunol       Date:  2017-02-28       Impact factor: 7.561

4.  Deletions in Genes Participating in Innate Immune Response Modify the Clinical Course of Andes Orthohantavirus Infection.

Authors:  Grazielle Esteves Ribeiro; Luis Edgardo Leon; Ruth Perez; Analia Cuiza; Pablo Agustin Vial; Marcela Ferres; Gregory J Mertz; Cecilia Vial
Journal:  Viruses       Date:  2019-07-25       Impact factor: 5.048

5.  Interferon lambda 4 impacts the genetic diversity of hepatitis C virus.

Authors:  M Azim Ansari; Elihu Aranday-Cortes; John McLauchlan; Vincent Pedergnana; Camilla Lc Ip; Ana da Silva Filipe; Siu Hin Lau; Connor Bamford; David Bonsall; Amy Trebes; Paolo Piazza; Vattipally Sreenu; Vanessa M Cowton; Emma Hudson; Rory Bowden; Arvind H Patel; Graham R Foster; William L Irving; Kosh Agarwal; Emma C Thomson; Peter Simmonds; Paul Klenerman; Chris Holmes; Eleanor Barnes; Chris Ca Spencer
Journal:  Elife       Date:  2019-09-03       Impact factor: 8.713

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.